SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.

News Shanghai Shyndec Pharmaceutical Co., Ltd.

Equities

600420

CNE000001JG2

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2026-03-13			5-day change	1st Jan Change
10.96 ^CNY	-0.09%		+1.20%	+8.51%

02-25	Shyndec Pharmaceutical Gets China Approval for Antidepressant	MT
02-12	Shyndec Pharmaceutical Secures Bids For 51 Drugs in China's Latest Procurement Program	MT

All News

02-25	Shyndec Pharmaceutical Gets China Approval for Antidepressant	MT
02-12	Shyndec Pharmaceutical Secures Bids For 51 Drugs in China's Latest Procurement Program	MT
02-09	Shyndec Pharmaceutical's Subsidiary Passes GMP Inspection	MT
01-27	Shanghai Shyndec Pharmaceutical's Attributable Profit Slides 13%	MT
01-26	Shanghai Shyndec Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01-13	Shyndec Pharmaceutical's Generic Drug Secures Approval for Antibiotic Consistency Evaluation	MT
12-26	Shyndec Pharmaceutical Gets China Nod for Antipsychotic	MT
12-12	Shyndec Pharma Gets Regulatory Approval for Cardiovascular Drug	MT
12-01	Shanghai Shyndec Pharmaceutical Gets Registration for Opioid Analgesic	MT
11-04	Shyndec Pharmaceutical Buys Rights for Lactulose Oral Solution	MT
25-10-29	Henan Yangsen Pharmaceutical Group Co., Ltd. completed the acquisition of an additional 51% stake in Shanghai Modern Hasen Pharmaceutical Co., Ltd. from Shanghai Shyndec Pharmaceutical Co., Ltd..	CI
25-10-29	Shanghai Shyndec Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
25-10-17	Henan Yangsen Pharmaceutical Group Co., Ltd. agreed to acquire an additional 51% stake in Shanghai Modern Hasen Pharmaceutical Co., Ltd. from Shanghai Shyndec Pharmaceutical Co., Ltd. for approximately CNY 110 million.	CI
25-10-13	Shyndec Pharmaceutical's Unit Gets Nod to Market Sitagliptin Phosphate	MT
25-09-23	Shyndec Pharmaceutical's Subsidiary Gets Nod to Add Specification to Vitamin B6 Injection	MT
25-09-18	Shyndec Pharma's Enalapril Maleate Tablets Passes Regulator's Consistency Evaluation	MT
25-09-17	Shyndec Pharmaceutical Gets Registration Certification for Penehyclidine Hydrochloride Injection	MT
25-09-01	Shyndec Pharma Obtains Drug Registration for Chest Pain Drug	MT
25-08-29	Shanghai Shyndec Pharmaceutical H1 net profit down 6.5% Y/Y	RE
25-08-08	Shyndec Pharma's Unit Gets Nod to Market Ketamine Hydrochloride	MT
25-07-29	Shyndec Pharmaceutical's Subsidiaries Get Registration Certificates for Two Drugs	MT
25-07-18	Shyndec Pharmaceutical's H1 Profit Slips 7%, Total Revenue Drops 18%	MT
25-07-17	Shanghai Shyndec Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-07-17	Shanghai Shyndec Pharmaceutical prelim H1 net profit down 6.5% Y/Y	RE
25-07-01	Shyndec Pharmaceutical Unit Gets Registration Certificate for Hypertension Drug in China	MT